In light of this, we aimed to assess the expression pattern of ER genes, ESR1 and ESR2, with MET and further explore their association with clinicopathologic features, prognostic factors, and clinical outcomes in breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.